Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
06 Sept 2013
Header
Header image
Highlight of the week

News

EFPIA Response to EMA Consultation on the Publication and Access to Clinical-Trial Data
05 September 2013

The European Federation of Pharmaceutical Industries and Associations, EFPIA, today finalised its comments on the European Medicines Agency’s draft policy on publication and access to [...] Read more

News

News

"A Roadmap for Sharing Clinical Trial Data" Event Video
06 September 2013

Full video coverage of the August 27 panel event "A Roadmap for Sharing Clinical Trial Data" is now available! Check out the EFPIA YouTube channel or the EFPIA website video wall

From our blog

From our blog

Continuing Towards a Responsible Data Transparency: EFPIA's EMA Submission on Clinical Trials Data Sharing
05 September 2013 by Richard Bergström

One word can make a huge difference. This became very clear to me as EFPIA finalised its submission to the European Medicines Agency’s draft policy [...] Read more

From our blog

319 Years of Perspective on Public Debt
04 September 2013 by Richard Torbett

The issue of public debt in Europe - and what to do about it - has obviously been a major source of political and economic [...] Read more

From our blog

EFPIA-PhRMA Commitments: Breaking Down the Basics of Commitment 4
05 September 2013 by Richard Bergström

After last week’s event on clinical trial data sharing, I am more convinced than ever that communication– with a variety of stakeholders and the broader [...] Read more

Videos

Video

Richard Bergström and Ben Goldacre debate the data sharing agreement

From the August 27 conference "A roadmap for sharing clinical trial data": Richard Bergström and Ben Goldacre debate the data sharing agreement.

View video

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail